Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · Real-Time Price · USD
9.50
-0.23 (-2.36%)
Jun 27, 2025, 1:48 PM - Market open

Quoin Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
655715-
Upgrade
Market Cap Growth
31.63%10.02%-29.65%-54.69%--
Upgrade
Enterprise Value
-3-2-5-421-
Upgrade
Last Close Price
9.7322.77171.68596.409555.01-
Upgrade
PB Ratio
0.970.580.860.9323.12-
Upgrade
P/TBV Ratio
1.020.610.951.03--
Upgrade
Debt / Equity Ratio
0.470.320.620.567.19-0.18
Upgrade
Quick Ratio
2.383.362.993.641.640.04
Upgrade
Current Ratio
2.573.573.153.791.790.06
Upgrade
Return on Equity (ROE)
-138.82%-120.55%-132.92%-232.68%--
Upgrade
Return on Assets (ROA)
-47.40%-42.72%-44.03%-48.59%-70.60%-87.18%
Upgrade
Return on Capital (ROIC)
-65.02%-55.88%-56.58%-68.43%--
Upgrade
Earnings Yield
-186.97%-168.23%-179.39%-136.30%-141.27%-
Upgrade
Buyback Yield / Dilution
-633.25%-420.43%----
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q